BACE1 and Alzheimer disease: Notably, PERK haploinsufficiency is sufficient to improve cholinergic neurodegeneration and memory deficits in AD mice,130 which also prevents BACE1 elevations and reduces amyloid‐β peptide levels and plaque burden in AD mouse model.130